Knownwell Builds A New Model For Obesity Care

Knownwell delivers weight-inclusive primary care and metabolic health treatment as demand for GLP-1 weight-loss drugs grows and telemedicine rules tighten.
Weight loss drugs for cats? Company launches clinical trial of GLP-1 implants in cats – ABC News

Weight loss drugs for cats? Company launches clinical trial of GLP-1 implants in cats ABC News Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets? The New York Times Ozempets: will weight-loss jabs for cats and dogs make them miserable? The Guardian ‘MEOW-1’: Could your pet be on weight loss drugs? Company launches clinical trial KOMO Ozempic for […]
GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk

ABSTRACT This rapid review aimed to evaluate the effects of GLP-1 RAs on eating behaviors and eating disorder risk. Databases were searched to January 2025 to identify studies evaluating GLP-1 RA treatment for adolescents or adults with obesity or Type 2 diabetes. Eligible studies reported adverse events, changes in eating disorder risk, or eating behaviors […]
Details of failed studies cast pall on Novo Nordisk’s GLP-1 as Alzheimer’s treatment – Reuters

Details of failed studies cast pall on Novo Nordisk’s GLP-1 as Alzheimer’s treatment Reuters
Details of failed studies cast pall on Novo Nordisk’s GLP-1 as Alzheimer’s treatment

The joint studies showed some improvement in a few biological measures of the disease, but most of the changes were small and not enough to make a difference in delaying cognitive decline.
A GLP-1 Receptor Agonist Fails to Slow Alzheimer’s Disease in a Phase 3 Trial

On the one hand there is a modest amount of evidence for GLP-1 receptor agonist drugs to produce beneficial effects on an aged metabolism that are unconnected to weight loss. On the other hand, when Big Pharma has a very successful drug, it will attempt to use that drug for every condition it can that […]
Why you could soon have an OzemPET: Test begins on miracle once-a-week shot for obese cats and dogs

As GLP-1 medications like Ozempic have exploded in popularity for humans, researchers from Cornell University are now working on adapting the blockbuster drugs for household pets.
Trump LIVE: Donald Trump Makes Shocking Admission On US Healthcare System, Slams Obamacare | US News

President Trump held his 9th cabinet meeting on Tuesday, highlighting how his administration’s work in negotiating healthcare with Democrats, calling Obamacare “horrible healthcare.” CMS Administrator Mehmet Oz joins ‘The Sunday Briefing’ to weigh in on Trump’s plan to overhaul U.S. healthcare, new data linking GLP-1 drugs to lower colon cancer deaths and the growing cases […]
Hims & Hers Expands Care Scope as Prescription Platforms Evolve

The renowned health and wellness platform, Hims & Hers Health, Inc.’s HIMS, business model links virtual consultations directly to prescription access and home delivery. Customers meet with independent licensed providers through affiliated medical groups, and when medication is deemed appropriate, prescriptions are routed into a fulfillment network that includes in-house pharmacies, a 503B outsourcing facility […]
Oral GLP-1 Receptor Agonist Orforglipron Beneficial for Adults With Obesity, T2DM

WEDNESDAY, Dec. 3, 2025 — The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an adjunct to lifestyle modification versus placebo for adults with obesity or overweight and type…